These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1530684

  • 21. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.
    Salmonson T, Danielson BG, Wikström B.
    Br J Clin Pharmacol; 1990 Jun; 29(6):709-13. PubMed ID: 2378790
    [Abstract] [Full Text] [Related]

  • 22. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions.
    Akahane K, Tojo A, Fukamachi H, Kitamura T, Saito T, Urabe A, Takaku F.
    Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329
    [Abstract] [Full Text] [Related]

  • 23. [Recombinant human erythropoietin in uremic patients in substitute treatment].
    Canaud B, Mion C.
    Rev Prat; 1992 Feb 15; 42(4):432-40. PubMed ID: 1604162
    [Abstract] [Full Text] [Related]

  • 24. The effect of human recombinant erythropoietin on iron absorption and hepatic iron in a rat model.
    Adams PC, Chau LA, Lin E, Muirhead N.
    Clin Invest Med; 1991 Oct 15; 14(5):432-6. PubMed ID: 1742921
    [Abstract] [Full Text] [Related]

  • 25. The clearance of a single i.v. bolus of recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes and its effects on erythropoiesis.
    Bowen D, Ehmer B, Neubert P, Lewis T, Jacobs A.
    Exp Hematol; 1991 Aug 15; 19(7):613-6. PubMed ID: 1716588
    [Abstract] [Full Text] [Related]

  • 26. The pharmacokinetics of recombinant human erythropoietin in Balkan endemic nephropathy patients.
    Ležaić V, Petković N, Marić I, Miljković B, Vučićević K, Simić-Ogrizović S, Pejovic V, Djukanović L.
    Nefrologia; 2013 Aug 15; 33(4):478-85. PubMed ID: 23897179
    [Abstract] [Full Text] [Related]

  • 27. Influence of nephrectomy on tumor necrosis factor clearance in a murine model.
    Bemelmans MH, Gouma DJ, Buurman WA.
    J Immunol; 1993 Mar 01; 150(5):2007-17. PubMed ID: 8436831
    [Abstract] [Full Text] [Related]

  • 28. Clinical pharmacology of recombinant human erythropoietin (r-HuEPO).
    Flaharty KK.
    Pharmacotherapy; 1990 Mar 01; 10(2 ( Pt 2)):9S-14S. PubMed ID: 2345710
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human erythropoietin prevents lipopolysaccharide-induced vascular hyporeactivity in the rat.
    di Villa Bianca Rd, Sorrentino R, Mitidieri E, Marzocco S, Autore G, Thiemermann C, Pinto A, Sorrentino R.
    Shock; 2009 May 01; 31(5):529-34. PubMed ID: 18838949
    [Abstract] [Full Text] [Related]

  • 30. Potassium depletion enhances renal compensatory hypertrophy in the nephrectomized rat.
    Peterson LN, Carpenter B, Guttierrez GA, Fajardo C, Levine DZ.
    Miner Electrolyte Metab; 1987 May 01; 13(1):57-62. PubMed ID: 2438547
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Renal hemodynamic response to erythropoietin-induced polycythemia in 5/6 nephrectomised rats is different from normal rats.
    Paixão AD, Ferreira AT, Oshiro ME, Razvickas CV, Boim MA, Schor N.
    Exp Nephrol; 1998 May 01; 6(3):245-52. PubMed ID: 9639040
    [Abstract] [Full Text] [Related]

  • 34. Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats.
    Maitani Y, Moriya H, Shimoda N, Takayama K, Nagai T.
    Int J Pharm; 1999 Aug 05; 185(1):13-22. PubMed ID: 10425361
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reduction of risk following endotoxin injection in unilaterally nephrectomized rats.
    Zurovsky Y, Eligal Z.
    Exp Toxicol Pathol; 1995 Nov 05; 47(5):391-6. PubMed ID: 8871072
    [Abstract] [Full Text] [Related]

  • 37. Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability.
    Maitani Y, Hazama M, Tojo Y, Shimoda N, Nagai T.
    J Pharm Sci; 1996 Apr 05; 85(4):440-5. PubMed ID: 8901085
    [Abstract] [Full Text] [Related]

  • 38. Metabolism of pure human erythropoietin in the rat.
    Emmanouel DS, Goldwasser E, Katz AI.
    Am J Physiol; 1984 Jul 05; 247(1 Pt 2):F168-76. PubMed ID: 6742201
    [Abstract] [Full Text] [Related]

  • 39. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers.
    Jensen JD, Jensen LW, Madsen JK, Poulsen L.
    Eur J Haematol; 1995 Feb 05; 54(2):111-6. PubMed ID: 7698293
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure.
    Salmonson T, Danielson BG, Grahnén A, Wikström B.
    J Intern Med; 1990 Jul 05; 228(1):53-7. PubMed ID: 2384737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.